Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

581
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
581
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

971
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
971
Nephrons01:10

Nephrons

8.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
8.2K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

581
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
581
Renal Corpuscle01:20

Renal Corpuscle

8.3K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.3K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

295
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
295

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the commutability of lombardy region EQA control materials for enzymes, calcium, and creatinine.

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

Hypokalaemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle.

Genes·2025
Same author

Assessment of Safety and Efficacy of Expanded Hemodialysis with Medium Cut-Off Dialyzer Compared to Haemodiafiltration.

Journal of clinical medicine·2025
Same author

Advancements and challenges in high-sensitivity cardiac troponin assays: diagnostic, pathophysiological, and clinical perspectives.

Clinical chemistry and laboratory medicine·2025
Same author

Typical Clinical Presentation of an Autosomal Dominant Polycystic Kidney Disease Patient with an Atypical Genetic Pattern.

Genes·2025

Related Experiment Video

Updated: Mar 16, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

10.3K

Copeptin levels and kidney function in ADPKD: case-control study.

Valentina Corradi, Francesca Martino, Fiorella Gastaldon

    Clinical Nephrology
    |August 4, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Copeptin levels in autosomal dominant polycystic kidney disease (ADPKD) patients do not differ from controls and correlate with kidney function, not ADPKD itself. Further research is needed to confirm its prognostic value in early chronic kidney disease (CKD).

    More Related Videos

    Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
    07:35

    Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

    Published on: June 23, 2015

    12.1K
    Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
    08:13

    Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

    Published on: February 20, 2015

    14.0K

    Related Experiment Videos

    Last Updated: Mar 16, 2026

    Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
    08:46

    Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

    Published on: September 1, 2015

    10.3K
    Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
    07:35

    Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

    Published on: June 23, 2015

    12.1K
    Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
    08:13

    Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

    Published on: February 20, 2015

    14.0K

    Area of Science:

    • Nephrology
    • Biomarkers
    • Genetics

    Background:

    • Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disorder.
    • Previous studies suggested copeptin as a potential prognostic marker for kidney function decline in ADPKD.
    • It remains unclear if copeptin changes are specific to ADPKD or a general indicator of reduced glomerular filtration rate (GFR) in chronic kidney disease (CKD).

    Purpose of the Study:

    • To investigate whether copeptin levels are specific to ADPKD or correlate with GFR decline in CKD.
    • To evaluate the association between copeptin levels and estimated GFR (eGFR) in ADPKD and non-ADPKD (control) patients.

    Main Methods:

    • A case-control study involving 112 ADPKD patients and 112 controls.
    • Patients were stratified by GFR-stage (KDIGO).
    • Plasma levels of urea, creatinine, cystatin C, and copeptin were measured and correlated with eGFR (CKD-EPI).

    Main Results:

    • Median copeptin levels were similar between ADPKD (10.72 pmol/L) and control groups (12.32 pmol/L).
    • Copeptin levels increased progressively with declining GFR across all stages in both groups.
    • A significant inverse correlation was observed between copeptin levels and eGFR in both ADPKD (r = -0.81) and control (r = -0.76) groups.

    Conclusions:

    • Copeptin levels are strongly associated with overall renal function rather than the specific presence of ADPKD.
    • Prospective studies are warranted to assess copeptin's role as an early prognostic marker for ADPKD progression in CKD.